High Blood Pressure Strategy (HBPS)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2008 by Heart and Stroke Foundation of Ontario.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Sunnybrook Health Sciences Centre
Information provided by:
Heart and Stroke Foundation of Ontario
ClinicalTrials.gov Identifier:
NCT00446914
First received: March 12, 2007
Last updated: August 18, 2008
Last verified: August 2008
  Purpose

This program developed by the HSFO aims at helping people of Ontario and their primary healthcare providers better diagnose, manage and control high blood pressure. The High Blood Pressure Strategy brings together healthcare providers and patients to improve the way in which family doctors, nurse practitioners and pharmacists work together and with patients towards improved control of high blood pressure through the use of evidence-informed tools combined with local systems change.


Condition Intervention
Hypertension
Behavioral: Systems Change (High Blood Pressure Strategy)

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Official Title: High Blood Pressure Strategy: Hypertension Management Initiative Study

Resource links provided by NLM:


Further study details as provided by Heart and Stroke Foundation of Ontario:

Primary Outcome Measures:
  • Blood Pressure [ Time Frame: 36 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 5000
Study Start Date: January 2007
Estimated Study Completion Date: January 2010
Estimated Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)
Detailed Description:

Approximately 5,000 patients will participate in the study at 11 family practice sites throughout Ontario. Each of the 11 clinic sites will be randomised to either intervention or delayed intervention 9 months later. The intervention is a systems change involving interprofessional education and management tools to bring together physicians, nurses and pharmacists with the patient. Patients will be monitored by their family doctor or nurse practitioner at scheduled follow-up visits during a period of 36 months for an effect of the intervention over time on the patient's blood pressure.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adults aged 18 years or older
  • History of elevated BP reading or primary hypertension diagnosis

Exclusion Criteria:

  • Major mental health illness of cognitive impairment
  • Language barrier (unable to speak or read English)
  • Lives in a long-term care home
  • Secondary hypertension
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00446914

Contacts
Contact: Sheldon W Tobe, MD, FRCP(C) 416-480-6901 sheldon.tobe@sunnybrook.ca

Locations
Canada, Ontario
Heart and Stroke Foundation of Ontario Recruiting
Toronto, Ontario, Canada, M4P1E4
Contact: Margaret Moy Lum-Kwong, BSc.N, MBA, CHE    416-489-7111 ext 445    moylumkwong@hsf.on.ca   
Contact: Shirley Von Sychowski, BA, MA    416-489-7111 ext 339    svsychowski@hsf.on.ca   
Sponsors and Collaborators
Heart and Stroke Foundation of Ontario
Sunnybrook Health Sciences Centre
Investigators
Principal Investigator: Sheldon W Tobe, MD, FRCP(C) Sunnybrook Health Sciences Centre
Principal Investigator: Margaret Moy Lum-Kwong, BSc.N., MBA, CHE Heart and Stroke Foundation of Ontario
Principal Investigator: Shirley Von Sychowski, BA, MA Heart and Stroke Foundation of Ontario
  More Information

No publications provided by Heart and Stroke Foundation of Ontario

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Sheldon Tobe, Sunnybrook Health Sciences Centre
ClinicalTrials.gov Identifier: NCT00446914     History of Changes
Obsolete Identifiers: NCT00425828
Other Study ID Numbers: 474-2006
Study First Received: March 12, 2007
Last Updated: August 18, 2008
Health Authority: Canada: Ethics Review Committee

Keywords provided by Heart and Stroke Foundation of Ontario:
Hypertension
Blood Pressure

Additional relevant MeSH terms:
Hypertension
Vascular Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on August 18, 2014